NHS to lose out on new drugs, pharma firm warns

Swiss firm Novartis said it was not considering the UK for major new investments in manufacturing, research, or advanced technology because of "systemic barriers". In 2023 a deal was done with predictions of how big the rebate should be that pharma companies would have to pay the UK government on sa...